Published in J Pharmacol Exp Ther on March 03, 2009
Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry (2010) 1.63
Recent advances in the design and development of novel negative allosteric modulators of mGlu(5). ACS Chem Neurosci (2011) 1.60
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol (2009) 1.48
The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry (2011) 1.28
Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur J Pharmacol (2010) 1.12
Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. Biol Psychiatry (2010) 1.08
Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther (2009) 1.08
Role of mGluR5 neurotransmission in reinstated cocaine-seeking. Addict Biol (2012) 1.06
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats. Bioorg Med Chem Lett (2010) 1.05
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine. Psychopharmacology (Berl) (2010) 1.02
Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors. Addict Biol (2010) 1.02
Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement. Addict Biol (2014) 0.99
Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration. Brain Res (2011) 0.94
The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning. Addict Biol (2013) 0.93
Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5). PLoS One (2010) 0.91
Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys. J Pharmacol Exp Ther (2012) 0.91
The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front Behav Neurosci (2014) 0.89
Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology (Berl) (2011) 0.88
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. Bioorg Med Chem Lett (2013) 0.88
Positive Allosteric Modulation of mGluR5 Accelerates Extinction Learning but Not Relearning Following Methamphetamine Self-Administration. Front Pharmacol (2012) 0.88
Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol (2014) 0.87
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine. Psychopharmacology (Berl) (2010) 0.86
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction. ACS Chem Neurosci (2011) 0.86
The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats. Exp Clin Psychopharmacol (2014) 0.85
Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci (2015) 0.84
Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addiction. ACS Chem Neurosci (2013) 0.84
The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice. PLoS One (2013) 0.83
The mGluR5 antagonist MTEP dissociates the acquisition of predictive and incentive motivational properties of reward-paired stimuli in mice. Neuropsychopharmacology (2010) 0.83
(-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking. Addict Biol (2011) 0.83
Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking. Neuroreport (2014) 0.82
Impact of mGluR5 during amphetamine-induced hyperactivity and conditioned hyperactivity in differentially reared rats. Psychopharmacology (Berl) (2011) 0.82
A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. Addict Biol (2013) 0.81
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. Bioorg Med Chem Lett (2014) 0.81
Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. Psychopharmacology (Berl) (2013) 0.81
Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neurosci Lett (2015) 0.80
Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. J Addict Res Ther (2011) 0.80
The paraventricular nucleus of the thalamus is differentially recruited by stimuli conditioned to the availability of cocaine versus palatable food. Addict Biol (2015) 0.80
Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans. Mol Psychiatry (2013) 0.80
Withdrawal from cocaine self-administration and yoked cocaine delivery dysregulates glutamatergic mGlu5 and NMDA receptors in the rat brain. Neurotox Res (2014) 0.79
Environmental condition alters amphetamine self-administration: role of the MGluR₅ receptor and schedule of reinforcement. Psychopharmacology (Berl) (2015) 0.78
Corticostriatal circuitry in regulating diseases characterized by intrusive thinking. Dialogues Clin Neurosci (2016) 0.77
Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction. Psychopharmacology (Berl) (2014) 0.77
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window. Int J Neuropsychopharmacol (2016) 0.77
The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues. Br J Pharmacol (2016) 0.76
mGlu5 Receptors and Relapse to Cocaine-Seeking: The Role of Receptor Trafficking in Postrelapse Extinction Learning Deficits. Neural Plast (2016) 0.76
mGlu receptors and drug addiction. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.76
Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict Biol (2016) 0.75
N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents. Bioorg Med Chem Lett (2016) 0.75
Effects of metabotropic glutamate receptor ligands on male sexual behavior in rats. Neuropharmacology (2012) 0.75
Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol (1997) 10.26
Progressive ratio as a measure of reward strength. Science (1961) 6.57
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods (1996) 6.41
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) (2000) 5.19
Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci (1996) 3.66
The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology (2005) 3.28
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov (2005) 3.15
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci (2001) 3.09
Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) (2002) 2.79
Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology (Berl) (1998) 2.27
Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J (2001) 2.17
3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem (2003) 2.17
Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci (2004) 1.99
The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci (2004) 1.90
Differential involvement of orbitofrontal cortex subregions in conditioned cue-induced and cocaine-primed reinstatement of cocaine seeking in rats. J Neurosci (2004) 1.87
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev (2006) 1.86
Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology (2006) 1.84
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) (2003) 1.83
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology (2004) 1.83
Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci (1993) 1.65
(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology (1997) 1.61
Persistent cue-evoked activity of accumbens neurons after prolonged abstinence from self-administered cocaine. J Neurosci (2003) 1.52
The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol (2004) 1.50
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) (2005) 1.49
Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther (2004) 1.46
The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories. Behav Neurosci (2007) 1.34
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology (2005) 1.34
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). Eur J Pharmacol (2003) 1.33
Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology (2007) 1.32
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol (2003) 1.28
Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann N Y Acad Sci (2003) 1.28
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl) (2005) 1.27
Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci (2003) 1.25
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology (2002) 1.24
Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J Neurochem (1998) 1.24
Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat Neurosci (1999) 1.17
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur Neuropsychopharmacol (2006) 1.14
Metabotropic glutamate receptors--important modulators of nociception and pain behavior. Pain (2002) 1.03
Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology (Berl) (1993) 0.94
Hippocampal N-methyl-D-aspartate receptor-mediated encoding and retrieval processes in spatial working memory: delay-interposed radial maze performance in rats. Neuroscience (2004) 0.92
Hypofunction of the dorsal hippocampal NMDA receptors impairs retrieval of memory to partially presented foreground context in a single-trial fear conditioning in rats. Eur Neuropsychopharmacol (2005) 0.85
The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats. Neuropharmacology (2005) 0.85
BTCP is a potent reinforcer in rats: comparison of behavior maintained on fixed- and progressive-ratio schedules. Pharmacol Biochem Behav (2002) 0.84
Effects of psychomotor stimulants on glutamate receptor expression. Methods Mol Med (2003) 0.81
Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research. NIDA Res Monogr (1997) 0.79
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci (1995) 2.70
The dopamine hypothesis of reward: past and current status. Trends Neurosci (1999) 2.68
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res (1998) 2.38
Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci (1998) 2.12
Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci U S A (2001) 2.06
Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) (2001) 1.94
Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci U S A (1984) 1.50
Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport (2000) 1.43
Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav (1997) 1.29
In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse (1999) 1.28
Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res (1999) 1.23
Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. J Pharmacol Exp Ther (1999) 1.21
The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann N Y Acad Sci (1994) 1.16
Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. Antimicrob Agents Chemother (1976) 1.16
Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology (1999) 1.15
Detection of partial anomalous pulmonary venous connection by magnetic resonance imaging. Pediatr Cardiol (2005) 1.13
Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol (2000) 1.12
Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther (1995) 1.10
Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res (1989) 1.09
Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats: a quantitative microdialysis study. Alcohol Clin Exp Res (2001) 1.07
Estrous cycle effects on operant responding for ethanol in female rats. Alcohol Clin Exp Res (1998) 1.06
Serotonin1B receptor stimulation enhances cocaine reinforcement. J Neurosci (1998) 1.05
Outbreak of listerosis due to imported cooked ham, Switzerland 2011. Euro Surveill (2013) 1.05
Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. J Pharmacol Exp Ther (2007) 1.05
Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. Alcohol Clin Exp Res (2001) 1.04
Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res Monogr (1994) 1.02
Antimetabolites produced by microorganisms. II. L-2-amino-4-pentynoic acid. J Antibiot (Tokyo) (1971) 1.02
Propensity to 'relapse' following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei. Neuroscience (2011) 1.01
Nanoelectrospray mass spectrometry and precursor ion monitoring for quantitative steroid analysis and attomole sensitivity. Anal Chem (1999) 1.01
Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcohol Clin Exp Res (2000) 1.00
Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology (Berl) (1996) 0.99
Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport (2001) 0.99
[Migration of a biliary Tannenbaum stent with perforation of sigmoid diverticulum]. Rofo (2001) 0.99
Alcohol, the reward system and dependence. EXS (1994) 0.98
Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem (1997) 0.96
The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Ann N Y Acad Sci (1993) 0.92
Rapid induction of tumor necrosis factor alpha in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay. Proc Natl Acad Sci U S A (1995) 0.91
Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett (1995) 0.90
The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci Lett (1990) 0.90
Measures of cocaine-seeking behavior using a multiple schedule of food and drug self-administration in rats. Drug Alcohol Depend (1995) 0.90
Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration. Behav Brain Res (1996) 0.90
Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valves. Eur Surg Res (2008) 0.89
Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides (2006) 0.89
Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience (1993) 0.88
Neuropharmacology of cocaine and ethanol dependence. Recent Dev Alcohol (1992) 0.88
Neurobiological processes in alcohol addiction. Alcohol Clin Exp Res (2001) 0.88
Pharmacology of drug self-administration. Alcohol (1990) 0.87
Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement. Psychopharmacology (Berl) (1996) 0.87
Recent research on alcohol tolerance and dependence. Alcohol Clin Exp Res (2001) 0.86
RU 24969, a 5-HT1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine. Synapse (1999) 0.86
Substance dependence as a compulsive behavior. J Psychopharmacol (1998) 0.85
Chronic footshock, but not a physiological stressor, suppresses the alcohol deprivation effect in dependent rats. Alcohol Alcohol (2004) 0.84
Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J Neurochem (1996) 0.84
Heroin-specific stimuli reinstate operant heroin-seeking behavior in rats after prolonged extinction. Pharmacol Biochem Behav (2000) 0.82
[Comparison of an edema-sensitive HASTE-TIRM sequence with delayed contrast enhancement in acute myocardial infarcts]. Rofo (2003) 0.82
Descending pathways from the paraventricular nucleus contribute to the recruitment of brainstem nuclei following a systemic immune challenge. Neuroscience (2003) 0.80
Evaluation of spatial and temporal resolution for ECG-gated 16-row multidetector CT using a dynamic cardiac phantom. Eur Radiol (2005) 0.80
Sympathetic vasomotor dysfunction in leprosy patients: comparison with electrophysiological measurement and qualitative sensation testing. Neurosci Lett (1996) 0.78
A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration. Brain Res (1994) 0.78
Animal models of craving: a roundtable discussion. Alcohol Res Health (1999) 0.77
Antimetabolites produced by microorganisms. VII. L-(N5-phosphono)methionine-S-sulfoximinyl-L-alanyl-L-alanine. J Antibiot (Tokyo) (1973) 0.76
Cutaneous leishmaniasis in kidney transplant recipient. Transplant Proc (2002) 0.75
Crico-pharyngeal spasm associated with cow milk protein allergy in infancy. Allergy (2007) 0.75
An improved method for adrenalectomy of suckling rats. The influence of thrombin treatment and deoxycorticosterone substitution on survival and on hepatic and renal enzyme activities. Biomed Biochim Acta (1986) 0.75
Behavioral and neurochemical effects of 3-OH-pip-BTCP, an active metabolite of BTCP in rats. Neuroreport (2001) 0.75
[Value of triple phase helical CT for the detection of hepatocellular carcinoma in cirrhotic liver]. Rofo (2002) 0.75
Raman study of CeO2 texture as a buffer layer in the CeO2/La2Zr2O7/Ni architecture for coated conductors. Appl Spectrosc (2009) 0.75
Body-image disturbances among obese adults: evaluation and treatment. Am J Psychother (1986) 0.75
Microbial products. III Epi-deoxynegamycin from a Micromonospora. J Antibiot (Tokyo) (1979) 0.75
Vasectomy technic using an auto-suture. Int Surg (1972) 0.75
Intramitochondrial bodies in a human cell line carrying oncornavirus-like particles. J Natl Cancer Inst (1975) 0.75
[AIDS--legal problems for physicians and assisting health personnel]. Krankenpfl J (1987) 0.75
On feeling abused and being abused. Am J Psychoanal (1974) 0.75
[Contribution to the differential diagnosis of the small spotted diffuse lung shadows]. Dtsch Gesundheitsw (1966) 0.75
Functional output of the basal forebrain. Adv Exp Med Biol (1991) 0.75
[Enteritis regionalis (Morbus Crohn)]. Langenbecks Arch Chir (1968) 0.75
Circulation and sensation at the fingertips of claw hands. Lepr Rev (1994) 0.75
Design and biomechanical evaluation of a cementable endosteal blade implant. J Biomed Mater Res (1976) 0.75
Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats. Pharmacol Biochem Behav (1986) 0.75
[Functional imaging of submandibular glands: diffusion-weighted echo-planar MRI before and after stimulation]. Rofo (2006) 0.75
Of Human Bondage. Am J Psychoanal (1973) 0.75
Simple microbore high-performance liquid chromatographic method for the determination of dopamine and cocaine from a single in vivo brain microdialysis sample. J Chromatogr B Biomed Sci Appl (1998) 0.75
Non reciprocal cross-sensitization between cocaine and BTCP on locomotor activity in the rat. Pharmacol Biochem Behav (2000) 0.75
[Imaging-based anatomy of the neck -- multi-slice CT and MRI]. Rofo (2004) 0.75
A new semisynthetic macrolide antibiotic 3-O-oleandrosyl-5-O-desosaminylerythronolide A oxime. J Antibiot (Tokyo) (1976) 0.75
Non-invasive follow up of an atrial septal defect device occlusion. Heart (2005) 0.75
An unusual presacral tumor. IMJ Ill Med J (1973) 0.75
Antimetabolites produced by microorganisms. XII (S)-alanyl-3-[alpha-(S)-chloro-3-(S)-hydroxy 2-oxo-3-azetidinylmethyl]-(S)-alanine, a new beta-lactam containing natural product. J Antibiot (Tokyo) (1975) 0.75
N-[1-(2-benzo[b]thiophenyl)Cyclohexyl]- piperidine (BTCP) exerts cocaine-like actions on drug-maintained responding in rats. Neuropsychopharmacology (2000) 0.75
[Diagnostic problems in the aspiration cytological study of the endometrium]. Med Welt (1983) 0.75
[Ultrafast MR sialography: comparison of two coil systems including an alternative surface coil]. Rofo (2008) 0.75
Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial. Eur J Vasc Endovasc Surg (2002) 0.75